These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 31912146)

  • 1. Integrative network analysis identifies cell-specific trans regulators of m6A.
    An S; Huang W; Huang X; Cun Y; Cheng W; Sun X; Ren Z; Chen Y; Chen W; Wang J
    Nucleic Acids Res; 2020 Feb; 48(4):1715-1729. PubMed ID: 31912146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
    Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
    J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer.
    Han X; Liu J; Cheng G; Cui S
    Cancer Control; 2020; 27(1):1073274820960460. PubMed ID: 32951457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA N6-methyladenosine modification, spermatogenesis, and human male infertility.
    Cai Z; Niu Y; Li H
    Mol Hum Reprod; 2021 May; 27(6):. PubMed ID: 33749751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.
    Chen J; Fang X; Zhong P; Song Z; Hu X
    RNA Biol; 2019 Aug; 16(8):991-1000. PubMed ID: 31107151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
    Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
    Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation.
    Lee JH; Wang R; Xiong F; Krakowiak J; Liao Z; Nguyen PT; Moroz-Omori EV; Shao J; Zhu X; Bolt MJ; Wu H; Singh PK; Bi M; Shi CJ; Jamal N; Li G; Mistry R; Jung SY; Tsai KL; Ferreon JC; Stossi F; Caflisch A; Liu Z; Mancini MA; Li W
    Mol Cell; 2021 Aug; 81(16):3368-3385.e9. PubMed ID: 34375583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions of RNA N6-methyladenosine modification in cancer progression.
    Chen B; Li Y; Song R; Xue C; Xu F
    Mol Biol Rep; 2019 Apr; 46(2):2567-2575. PubMed ID: 30911972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of periodontitis.
    Zhang X; Zhang S; Yan X; Shan Y; Liu L; Zhou J; Kuang Q; Li M; Long H; Lai W
    J Cell Mol Med; 2021 Apr; 25(7):3634-3645. PubMed ID: 33724691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shaping the landscape of N6-methyladenosine RNA methylation in Arabidopsis.
    Wong CE; Zhang S; Xu T; Zhang Y; Teo ZWN; Yan A; Shen L; Yu H
    Plant Physiol; 2023 Mar; 191(3):2045-2063. PubMed ID: 36627133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interplay between m6A RNA methylation and noncoding RNA in cancer.
    Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
    J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
    Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
    Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of the potential roles of m6A regulators in the uterus in pregnancy and infertility.
    Zhao S; Lu J; Chen Y; Wang Z; Cao J; Dong Y
    J Reprod Immunol; 2021 Aug; 146():103341. PubMed ID: 34116483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent progresses in RNA N6-methyladenosine research].
    Li YL; Yu J; Song SH
    Yi Chuan; 2013 Dec; 35(12):1340-51. PubMed ID: 24645343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review in Research Progress Concerning m6A Methylation and Immunoregulation.
    Zhang C; Fu J; Zhou Y
    Front Immunol; 2019; 10():922. PubMed ID: 31080453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-methyladenosine (m6A) modification and its clinical relevance in cognitive dysfunctions.
    Du B; Zhang Y; Liang M; Du Z; Li H; Fan C; Zhang H; Jiang Y; Bi X
    Aging (Albany NY); 2021 Aug; 13(16):20716-20737. PubMed ID: 34461609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts.
    Imam H; Kim GW; Mir SA; Khan M; Siddiqui A
    PLoS Pathog; 2020 Feb; 16(2):e1008338. PubMed ID: 32059034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
    Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m6A RNA methylation regulators could contribute to the occurrence of chronic obstructive pulmonary disease.
    Huang X; Lv D; Yang X; Li M; Zhang H
    J Cell Mol Med; 2020 Nov; 24(21):12706-12715. PubMed ID: 32961012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.